NIAID Fellow Thomas Platts-Mills.

Their newly reported findings are of immediate relevance for the treatment of cancer patients, says Dr. Platts-Mills. Because of the widespread use of cetuximab in the treatment of cancer, it may be useful to identify patients at the screen specific IgE antibodies specific IgE antibodies against cetuximab for those who are at risk for serious adverse reactions, including anaphylaxis. .. NIAID Fellow Thomas Platts-Mills, of Allergy and Clinical of Allergy and Clinical Immunology at the University of Virginia, conducted a study the cause the cause of the clinical problem with cetuximab.

The researchers hypothesized that these patients had pre-existing IgE antibodies that cross-reacted with cetuximab and that these IgE antibodies against a specific sugar molecule currently cetuximab cetuximab. This hypothesis was derived, in part, from knowledge that all people develop natural antibodies, the sugar found in foods, bacteria and viruses, although such antibodies are from a non-IgE class, called IgM.AMA president Dr Rosanna Cape Tongue , said today that AMA was can add direction on appreciates of the coalition plan to improve public hospitals and health care however view more happy to who viewed View Details of the implementation and financing.

Other articles from category "fitness":

Random articles